{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:01:23Z","timestamp":1786132883097,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1681\/asn.2014020157","type":"journal-article","created":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T00:05:48Z","timestamp":1415405148000},"page":"1216-1227","source":"Crossref","is-referenced-by-count":37,"title":["Isolated Endarteritis and Kidney Transplant Survival"],"prefix":"10.1681","volume":"26","author":[{"given":"Banu","family":"Sis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena M.","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmjeet","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Lategan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex B.","family":"Magil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Herzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kuperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-26-20230208","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: Global dimension and perspectives.","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"R3-26-20230208","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMp1114394","article-title":"Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.","volume":"366","author":"Gill","year":"2012","journal-title":"N Engl J Med"},{"key":"R4-26-20230208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss.","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"R5-26-20230208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"R6-26-20230208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"R7-26-20230208","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies.","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant"},{"key":"R8-26-20230208","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201909 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups.","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"R9-26-20230208","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/j.1600-6143.2007.02005.x","article-title":"Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.","volume":"7","author":"Mueller","year":"2007","journal-title":"Am J Transplant"},{"key":"R10-26-20230208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/ajt.12079","article-title":"Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies.","volume":"13","author":"Reeve","year":"2013","journal-title":"Am J Transplant"},{"key":"R11-26-20230208","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/ajt.12387","article-title":"Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study.","volume":"13","author":"Halloran","year":"2013","journal-title":"Am J Transplant"},{"key":"R12-26-20230208","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1399-0012.2012.01673.x","article-title":"Acute vascular rejection after renal transplantation and isolated v-lesion.","volume":"26","author":"Shimizu","year":"2012","journal-title":"Clin Transplant"},{"key":"R13-26-20230208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/tri.12227","article-title":"Clinical significance of isolated v lesions in paediatric renal transplant biopsies: Muscular arteries required to refute the diagnosis of acute rejection.","volume":"27","author":"Brown","year":"2014","journal-title":"Transpl Int"},{"key":"R14-26-20230208","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/ctr.12333","article-title":"Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations.","volume":"28","author":"Wu","year":"2014","journal-title":"Clin Transplant"},{"key":"R15-26-20230208","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions.","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"R16-26-20230208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R17-26-20230208","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R18-26-20230208","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R19-26-20230208","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant"},{"key":"R20-26-20230208","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ki.2013.44","article-title":"Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.","volume":"83","author":"Djamali","year":"2013","journal-title":"Kidney Int"},{"key":"R21-26-20230208","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: Current status and novel approaches.","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"R22-26-20230208","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: A population-based study.","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"R23-26-20230208","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1600-6143.2010.03415.x","article-title":"Inflammation lesions in kidney transplant biopsies: Association with survival is due to the underlying diseases.","volume":"11","author":"Sellar\u00e9s","year":"2011","journal-title":"Am J Transplant"},{"key":"R24-26-20230208","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R25-26-20230208","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"key":"R26-26-20230208","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: Results from the long-term extension of the BENEFIT study.","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"R27-26-20230208","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","article-title":"The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.","volume":"8","author":"Bluestone","year":"2008","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201505000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:25:26Z","timestamp":1786130726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201505000-00026"}},"subtitle":["A Multicenter Collaborative Study"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014020157","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}